Trivisc

Knee pain caused by osteoarthritis is suffered by millions of people worldwide10. TriVisc, a 3-injection Hyaluronic Acid from OrthogenRx, may help relieve OA-related knee pain in patients who are unresponsive to non-pharmacologic therapy and simple analgesics.

Reimbursement Code J7329

OA knee pain

Pure11

  • Highly purified HA produced by bacterial biofermentation technology
  • Removes the risk of avian allergies and sensitivities
  • Consistent viscoelastic properties, safe for repeat injection cycles
  • Fully automated manufacturing process minimizes the risk of contamination and human error

Trusted

  • 35 million doses administered worldwide12†
  • TriVisc efficacy established by equivalence to Visco-3 ®13
  • Visco-3 determined to be non-inferior to Euflexxa®14
  • Supported by published clinical data
  • TriVisc exhibited improvement in WOMAC, and VAS scores compared to baseline15,16,17

TriVisc Product Resources

Links to open new windows with PDFs:

$ Full Prescribing and Safety Information
$ Directions for Use
$ Clinical Compendium
$ Reimbursement Guide

35 Million doses administrated worldwide.18